Patent intelligence · US
US 7429562
Cyclosporin analog formulations
Cyclosporin analog formulations
Patent details — US 7429562
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 30, 2008
- Expiration
- Sep 25, 2028
- Applicant
- Isotechnika, Inc.
- Claims
- 31
- CPC classes
- A61K, A61K38/13, A61K47/10, A61K9/0095
Quick answer
US 7429562 (Cyclosporin analog formulations) is held by Isotechnika, Inc.. Status: granted. Granted Sep 30, 2008. Expires Sep 25, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Isotechnika, Inc.
- Grant date
- Expiration
- Claims
- 31
- CPC classes
- A61K, A61K38/13, A61K47/10, A61K9/0095, A61K9/1075, A61K9/4858
More from Isotechnika, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12415779
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted -
US 11939303
Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted
Frequently asked questions
What is US patent 7429562?
US 7429562 (Cyclosporin analog formulations) is held by Isotechnika, Inc.. Status: granted. Granted Sep 30, 2008. Expires Sep 25, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7429562?
Isotechnika, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 69 pharmaceutical patents for this assignee.
When does US 7429562 expire?
Our index shows an expiration date of Sep 25, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.